Eric Dobmeier

Eric Dobmeier is President and Chief Executive Officer of Chinook Therapeutics, a biotechnology company focused on precision medicines for kidney disease. He was previously President and Chief Executive Officer of Silverback Therapeutics, and prior to that was Chief Operating Officer of Seattle Genetics, overseeing business development, corporate communications, manufacturing and program/alliance management activities, as well as corporate strategy initiatives.